Article

Improvement of capecitabine antitumoral activity by melatonin in pancreatic cancer.

Department of Surgery, Reina Sofia University Hospital, Córdoba, Spain.
Pancreas (Impact Factor: 3.01). 12/2010; 40(3):410-4. DOI: 10.1097/MPA.0b013e318201ca4f
Source: PubMed

ABSTRACT The purpose of our study was to evaluate the effects of the addition of melatonin and capecitabine on experimental pancreatic cancer.
Fifty Syrian hamsters were randomized in 5 groups: group 1: no tumor induction (control group); group 2: tumor induction with BOP [N-nitrosobis(2-oxopropyl) amine]; group 3: tumor induction with BOP and melatonin administration; group 4: tumor induction with BOP and capecitabine administration; and group 5: tumor induction with BOP and administration of combined capecitabine and melatonin therapy. The evaluation of pathological tumor evolution and oxidative stress markers in pancreatic tissue was carried out.
All animals under BOP exposure presented poorly or moderately differentiated pancreatic adenocarcinoma associated with increased lipoperoxide levels and decreased antioxidant activity in pancreatic tissue. Pancreatic cancer was shown in only 66% of the capecitabine-treated group and 33% of melatonin-treated group (P < 0.05), most of them moderately differentiated adenocarcinoma. When capecitabine and melatonin were combined, a well-differentiated pancreatic adenocarcinoma was observed in 10% of animals. The beneficial effect was associated with a decrease in lipoperoxide levels and increased antioxidant activity in pancreatic tissue.
The combined administration of capecitabine and melatonin provided an improvement in antioxidant status as well as a synergistic antitumoral effect in experimental pancreatic cancer.

0 Followers
 · 
181 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Melatonin influences a number of physiological processes and is believed to play an antitumoral role in several types of cancers, but its impact on pancreatic cancer is not fully clarified. The growth inhibitory effect of melatonin on pancreatic cancer cell line SW-1990 was detected in vitro and in vivo. Annexin V/PI assay was applied to detect apoptosis and necrosis in SW-1990 cells. Changes of Bcl-2 and Bax expression were investigated by RT-PCR and Western blot. An obvious growth inhibition was found in SW-1990 after melatonin or combined treatment with melatonin and gemicitabine through both apoptosis and necrosis in vitro, and also found in transplanted tumors in nude mice. RT-PCR and Western blot showed that Bcl-2 expression was downregulated, while Bax expression was upregulated, after melatonin treatment. Melatonin may be a pro-apoptotic and pro-necrotic agent for pancreatic cancer cells via its modulation of Bcl-2/Bax balance.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 11/2012; 67(2). DOI:10.1016/j.biopha.2012.10.005 · 2.11 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this paper, two strategies based on the slope pulsewidth modulation (PWM) technique are applied to acoustic noise reduction in inverter-fed induction motors. This generated technique uses a trapezoidal modulator wave with a triangular or a sinusoidal carrier signal. The main advantage of the proposed method is that only two control parameters are necessary to achieve a voltage spectrum configuration that helps reduce radial electromagnetic forces. One of them modifies the amplitude of the modulated output of the inverter, and the other controls the frequency spectrum distribution. Small changes to these parameters can yield a wide range of electrical spectra that allow for selective acoustic harmonic reduction. Thus, it is possible to avoid the overlap of radial forces produced by the MMF time harmonic frequencies of the inverter and the radial forces produced by the MMF space harmonic frequencies due to the discretized distribution of stator winding in slots of the motor, maintaining the number of pulses per period chosen. Also, it can help to avoid activating the resonances due to the mechanical natural frequencies. Results are checked experimentally and compared to those of other PWM techniques.
    IEEE Transactions on Industrial Electronics 07/2013; 60(7):2555-2563. DOI:10.1109/TIE.2012.2196892 · 6.50 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In the present work, we have evaluated the effect of an acute addition of melatonin on cholecystokinin octapeptide (CCK-8)-evoked Ca(2+) signals and amylase secretion in mouse pancreatic acinar cells. For this purpose, freshly isolated mouse pancreatic acinar cells were loaded with fura-2 to study intracellular free Ca(2+) concentration ([Ca(2+)]c). Amylase release and cell viability were studied employing colorimetric methods. Our results show that CCK-8 evoked a biphasic effect on amylase secretion, finding a maximum at a concentration of 0.1 nM and a reduction of secretion at higher concentrations. Pre-incubation of cells with melatonin (1 μM-1 mM) significantly attenuated enzyme secretion in response to high concentrations of CCK-8. Stimulation of cells with 1 nM CCK-8 led to a transient increase in [Ca(2+)]c, followed by a decrease towards a constant level. In the presence of 1 mM melatonin, stimulation of cells with CCK-8 resulted in a smaller [Ca(2+)]c peak response, a faster rate of decay of [Ca(2+)]c and lower values for the steady state of [Ca(2+)]c, compared with the effect of CCK-8 alone. Melatonin also reduced the oscillatory pattern of Ca(2+) mobilization evoked by a physiological concentration of CCK-8 (20 pM), and completely inhibited Ca(2+) mobilization induced by 10 pM CCK-8. On the other hand, Ca(2+) entry from the extracellular space was not affected in the presence of melatonin. Finally, melatonin alone did not change cell viability. We conclude that melatonin, at concentrations higher than those found in blood, might regulate exocrine pancreatic function via modulation of Ca(2+) signals.
    Journal of physiology and biochemistry 08/2013; 69(4). DOI:10.1007/s13105-013-0267-2 · 2.50 Impact Factor